redcordial - it's both actually but the necessity to continue the use of interferon-based treatment regimens in over 80% of patients is more of a striking concern to me than combination with ribavirin. (ref: Approval of Sovaldi (sofosbuvir) tablets for the treatment of chronic hepatitis C (FDA)).
Benitec is targeting genotype 1 in the upcoming trial, by the way.
old myth of curing hepc with antisense, page-10
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)